您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2014, Vol. 52 ›› Issue (7): 22-27.doi: 10.6040/j.issn.1671-7554.0.2014.175

• 基础医学 • 上一篇    下一篇

胰岛素对前列腺癌LNCaP细胞的抑制作用

王琛, 唐悦清, 闫磊, 焦伟, 周尊林, 徐忠华   

  1. 山东大学齐鲁医院泌尿外科, 山东 济南 250012
  • 收稿日期:2014-03-28 修回日期:2014-05-27 出版日期:2014-07-10 发布日期:2014-07-10
  • 通讯作者: 徐忠华。E-mail：xuzhonghua1963@163.com；周尊林。E-mail：zhouzunlin117@163.com E-mail:xuzhonghua1963@163.com;zhouzunlin117@163.com
  • 基金资助:
    山东省科学技术发展项目（26010104011178）

Inhibitory effect of insulin on prostate cancer LNCaP cell line

WANG Chen, TANG Yueqing, YAN Lei, JIAO Wei, ZHOU Zunlin, XU Zhonghua   

  1. Department of Urology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2014-03-28 Revised:2014-05-27 Online:2014-07-10 Published:2014-07-10

PDF (PC)

917

摘要： 目的 观察胰岛素对前列腺癌LNCaP细胞系增殖、活力、迁移与侵袭能力的影响，并探讨其机制。方法 胰岛素刺激LNCaP细胞后，采用实时荧光定量聚合酶链反应（Real-time PCR）、蛋白免疫印迹（Western blotting）、免疫细胞化学（ICC）法检测胰岛素受体表达变化；细胞计数法、四唑盐法（MTT）、细胞划痕、细胞侵袭实验（Transwell）检测细胞增殖、活力、迁移和侵袭能力；Western blotting检测Ras、ERK1/2、MEK1/2蛋白水平表达变化。结果 胰岛素可促进LNCaP细胞胰岛素受体的表达，抑制其增殖、活力、迁移及侵袭能力，同时抑制其Ras的表达及ERK1/2、MEK1/2的磷酸化（P<0.05）。结论 胰岛素可通过胰岛素受体抑制Ras-MEK-ERK信号通路的活化，从而抑制LNCaP细胞的增殖、活力、迁移及侵袭。

关键词: 胰岛素受体, MAPK信号通路, 胰岛素, 前列腺肿瘤

Abstract: Objective To study the inhibitory effect of insulin on LNCaP human prostate cancer cell line and its possible mechanism. Methods After LNCaP cells were treated with insulin, the expression of insulin receptor was detected with Real-time PCR, immunocytochemistry and Western blotting. The effects of insulin on cell growth, viability, migration and invasion were measured by cell counting, MTT, wound healing and Transwell. The activation of MAPK pathway was determined by Western blotting. Results Insulin increased the mRNA and protein expressions of INSR in LNCaP cells, and inhibited the cell growth, viability, migration and invasion. Expressions of key proteins in the MAPK pathway, including Ras, p-MEK and p-ERK, were significantly lowered by insulin. Conclusion Insulin can inhibit prostate cancer LNCaP cell line through MAPK signal pathway.

Key words: Insulin receptor, Prostatic neoplasms, MAPK pathway, Insulin

中图分类号: 

  • R737.25
[1] Jemal A, Bray F, Center M M, et al. Global cancer statistics CA cancer[J]. CA Cancer J Clin, 2011, 61(2):69-90.
[2] 唐志柳, 白洁, 顾丽娜, 等. 2000～2010年我国前列腺癌和乳腺癌流行状况的系统性综述[J]. 中国肿瘤, 2013, 22(4):260-265.
[3] Saman D M, Lemieux A M, Nawal Lutfiyya M, et al. A review of the current epidemiology and treatment options for prostate cancer[J]. Dis Mon, 2014, 60(4):150-154.
[4] Lawrenson R, Obertová Z, Brown C, et al. The use of androgen deprivation therapy and chemotherapeutic agents in New Zealand men with prostate cancer[J]. J Cancer, 2014, 5(3):214-220.
[5] Kasper J S, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer[J]. Cancer Epidemiol Biomarkers Prev, 2006, 15(11): 2056-2062.
[6] Rodriguez C, Patel A V, Mondul A M, et al. Diabetes and risk of prostate cancer in a prospective cohort of US men[J]. Am J Epidemiol, 2005, 161(2): 147-152.
[7] Stagi S, Lapi E, Pantaleo M, et al. Type II diabetes and impaired glucose tolerance due to severe hyperinsulinism in patients with 1p36 deletion syndrome and a Prader-Willi-like phenotype[J]. BMC Med Genet, 2014, 15:16. doi:10.1186/1471-2350-15-16
[8] Leitzmann M F, Ahn J, Albanes D, et al. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial[J]. Cancer Causes Control, 2008, 19(10):1267-1276.
[9] Zelenko Z, Gallagher E J. Diabetes and Cancer[J]. Endocrinol Metab Clin North Am, 2014, 43(1):167-185.
[10] Starup-Linde J, Karlstad O, Eriksen S A, et al. CARING: the association of diabetes mellitus and cancer risk with focus on possible determinants—a systematic review and a meta-analysis[J]. Curr Drug Saf, 2013, 8(5):296-332.
[11] Wang Y, Zhu Y, Tian W, et al. Insulin promotes proliferation, survival, and invasion in endometrial carcinoma by activating the MEK/ERK pathway[J]. Cancer Lett, 2012, 322(2):223-231.
[12] Sehiel R, Behschikow W, Steiner T, et al. Diabetes, insulin, and risk of cancer[J]. Methods Find Exp Clin Pharmacol, 2006, 28(3):169-175.
[13] Ametov A S. The contribution of current investigations to understanding the nature of type 2 diabetes mellitus, and treatment perspectives[J]. Ter Arkh, 2014, 86(1):4-9.
[14] 仲英洁, 胡云. 胰岛素抵抗和胰岛素受体亚型A与肿瘤[J]. 医学综述, 2012, 18(3): 339-341.
[15] J Sánchez-Gurmaches, L Cruz-Garcia, A Ibarz, et al. Insulin, IGF-I, and muscle MAPK pathway responses after sustained exercise and their contribution to growth and lipid metabolism regulation in gilthead sea bream[J]. Domest Anim Endocrinol, 2013, 45 (3):145-153.
[16] Neal C L, Mckeithen D, Odero-Marah V A. Snail negatively regulates cell adhesion to extracellular matrix and integrin expression via the MAPK pathway in prostate cancer cells[J]. Cell Adh Migr, 2011, 5(3):249-257.
[17] 高庆贞, 吕家驹, 张辉, 等. 阻断MAPK通路对前列腺癌细胞增殖的影响[J]. 山东大学学报:医学版, 2006, 44(5): 501-503.
[18] Bakin R E, Gioeli D, Sikes R A, et al. Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells[J]. Cancer Res, 2003, 63(8):1981-1989.
[1] 张士宝 刘庆勇 阮喜云 陈杰 张建军 李宗武 杨广笑 王全颖. NT4-SAC-HA2-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[2] 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-.
[3] 王雪梅,杨豪,宋洋,程世超,张婷婷,王艳春. 抗糖尿病药物与女性恶性肿瘤的因果关联:一项两样本孟德尔随机化分析[J]. 山东大学学报 (医学版), 2025, 63(6): 67-77.
[4] 刘淋,王晓楠,杨雅溪,王江腾,李旭,周新丽,管庆波,张栩. 甘油三酯-葡萄糖指数与颅内动脉粥样硬化性狭窄的相关性[J]. 山东大学学报 (医学版), 2024, 62(8): 93-100.
[5] 许沛晨,李晓博,庄向华,娄能俊,吕丽,周玲雁,牟亚朋,宋玉文,陈诗鸿. 儿童Alstrom综合征2例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(3): 107-111.
[6] 王新起,徐晶晶,许旺旺,张洋,高进. 25(OH)D、IGF-I及焦虑、抑郁症状与门诊青少年精神障碍患者非自杀性自伤的关系[J]. 山东大学学报 (医学版), 2024, 62(12): 59-64.
[7] 张振伟,李佳,陈克明. IGF2BP2/m6A/ITGA5信号轴调控肾透明细胞增殖和迁移[J]. 山东大学学报 (医学版), 2022, 60(9): 74-84.
[8] 赵美茹,朱迪,刘淋,管庆波,张栩. 简易胰岛素抵抗指标与698例2型糖尿病患者发生高尿酸血症风险的关联[J]. 山东大学学报 (医学版), 2022, 60(12): 44-51.
[9] 封海岗,刘国文,曹洪. 干扰MAD2L1基因表达对乳腺癌细胞凋亡的影响及机制[J]. 山东大学学报 (医学版), 2022, 60(10): 9-16.
[10] 牛群,石婧婧,符江. WNT5A基因对卵巢颗粒细胞胰岛素反应性和胰岛素抵抗的调控作用[J]. 山东大学学报 (医学版), 2021, 59(6): 57-63.
[11] 罗慧臣,胡丹慧,张济. miR-203-3p靶向TREM1基因调控TGF-β1/p38MAPK信号通路对狼疮性肾炎小鼠肾小管上皮细胞增殖和凋亡的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 18-25.
[12] 哈灵侠,殷婷,吴阳阳,黎维霞,杜玉冬. 多囊卵巢综合征患者中胰岛素抵抗与子宫内膜局部炎症因子及葡萄糖转运蛋白-4表达的相关性[J]. 山东大学学报 (医学版), 2021, 59(11): 41-47.
[13] 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60-66.
[14] 徐红照,郝宗山, 沈德嫱,李朝苹,陈立勇. 核糖体蛋白S6激酶2沉默在乙醇诱导的心肌胰岛素抵抗中的作用[J]. 山东大学学报 (医学版), 2020, 58(4): 84-89.
[15] 徐焱焱,颜贝,王锐,王红燕. 经血间充质干细胞通过IGF-1信号通路改善小鼠卵巢早衰[J]. 山东大学学报 (医学版), 2020, 58(2): 13-20.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发